YLR255C Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target

YLR255C Antibody is a rabbit-derived polyclonal antibody designed to recognize the protein encoded by the YLR255C gene in S. cerevisiae. The gene is classified as a "dubious" ORF with no confirmed biological function, though it is conserved across fungal species . The antibody’s immunogen is the recombinant YLR255C protein (UniProt ID: O13574.1) .

Key characteristics include:

  • Host species: Rabbit

  • Reactivitiy: Specific to S. cerevisiae strain ATCC 204508/S288c .

  • Applications: ELISA, Western Blot (WB) .

Research Applications

The YLR255C antibody is utilized in several experimental workflows:

  • ELISA: Detects and quantifies the YLR255C protein in heterogeneous samples .

  • Western Blot: Identifies the protein’s presence and approximate molecular weight in lysates .

  • Immunoprecipitation: Isolates the YLR255C protein for downstream interaction studies .

Despite its applications, the lack of functional annotation for YLR255C limits interpretative insights. Researchers often pair this antibody with genomic or proteomic screens to infer potential roles in yeast biology .

Genomic Context

  • Genetic Status: Classified as a dubious ORF due to insufficient evidence for protein-coding function .

  • Sequence Conservation: Homologs exist in Ashbya gossypii and other fungi, suggesting evolutionary retention .

Experimental Data

  • Expression: No high-throughput expression data or phenotypic profiles are publicly available .

  • Interaction Networks: No documented protein-protein interactions in databases like BioGRID or STRING .

Limitations

  • The antibody’s utility is constrained by the unknown biological role of YLR255C.

  • Cross-reactivity with other yeast proteins has not been comprehensively ruled out .

Future Directions

Further studies could focus on:

  • Functional Characterization: CRISPR knockout screens to assess phenotypic impacts.

  • Localization Studies: Subcellular tracking via immunofluorescence .

  • Post-Translational Modifications: Mass spectrometry to identify modifications .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR255C antibody; Uncharacterized protein YLR255C antibody
Target Names
YLR255C
Uniprot No.

Q&A

What is YLR255C and why is it significant for yeast biology research?

YLR255C is classified as a "dubious" open reading frame (ORF) in Saccharomyces cerevisiae with no confirmed biological function, though it displays evolutionary conservation across fungal species. Despite its designation as dubious, the conservation pattern suggests potential functional significance that has not yet been experimentally validated. The protein is encoded by the YLR255C gene in S. cerevisiae strain ATCC 204508/S288c and has a UniProt ID of O13574.1. The antibody's significance lies in its utility for investigating poorly characterized yet conserved elements of the yeast proteome, potentially revealing novel aspects of fungal biology through targeted detection methods.

What are the key characteristics of the YLR255C Antibody?

The YLR255C Antibody is a rabbit-derived polyclonal antibody specifically designed to recognize the protein encoded by the YLR255C gene. Its primary characteristics include:

  • Host species: Rabbit

  • Reactivity: Specific to Saccharomyces cerevisiae strain ATCC 204508/S288c

  • Immunogen: Recombinant YLR255C protein (UniProt ID: O13574.1)

  • Applications: ELISA, Western Blot, and Immunoprecipitation

The antibody targets a protein encoded by a gene classified as dubious, yet the antibody itself demonstrates specific binding capacities useful for various experimental applications in yeast biology research.

What experimental applications is the YLR255C Antibody suitable for?

The YLR255C Antibody has been validated for multiple experimental workflows commonly used in molecular and cellular biology research:

  • ELISA (Enzyme-Linked Immunosorbent Assay): For detecting and quantifying the YLR255C protein in heterogeneous biological samples.

  • Western Blot: For identifying the presence and approximate molecular weight of the YLR255C protein in cell or tissue lysates.

  • Immunoprecipitation: For isolating the YLR255C protein and potential binding partners for downstream interaction studies.

These applications enable researchers to investigate the expression patterns, molecular characteristics, and potential binding partners of YLR255C, despite its currently undefined biological role.

How can I validate the specificity of YLR255C Antibody given its target is a dubious ORF?

Validating antibody specificity for a dubious ORF like YLR255C requires a multi-faceted approach:

  • Genetic knockout controls: Generate a YLR255C deletion strain as a negative control. If the antibody signal disappears in Western blots or immunoprecipitation experiments using this knockout strain, this provides strong evidence for specificity.

  • Recombinant protein competition assay: Pre-incubate the antibody with purified recombinant YLR255C protein before performing immunodetection. Specific binding should be competitively inhibited.

  • Cross-reactivity assessment: Test the antibody against lysates from related yeast species with varying degrees of YLR255C homology to assess potential cross-reactivity patterns.

  • Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry analysis to confirm that the captured protein is indeed YLR255C.

  • Epitope mapping: Identify the specific epitope(s) recognized by the antibody and verify their uniqueness within the yeast proteome through computational analyses.

These validation approaches are particularly important given the dubious status of YLR255C and the lack of functional annotation, which can otherwise complicate interpretation of experimental results.

What strategies can be employed to investigate potential functions of YLR255C using its antibody?

Despite YLR255C's classification as a dubious ORF, several research strategies can leverage the antibody to investigate potential functions:

  • Proteomics-based interaction studies: Use the antibody for immunoprecipitation followed by mass spectrometry to identify potential binding partners, which may provide functional context.

  • Subcellular localization: Employ the antibody in immunofluorescence microscopy to determine where YLR255C localizes within yeast cells under various conditions.

  • Expression profiling: Utilize the antibody in Western blots to track YLR255C expression across different growth conditions, stress responses, or cell cycle stages.

  • Post-translational modification analysis: Immunoprecipitate YLR255C followed by modification-specific detection methods to identify regulatory modifications.

  • Comparative expression analysis: Compare expression patterns in S. cerevisiae with orthologous proteins in other fungal species where homologs exist, such as Ashbya gossypii.

  • Synthetic genetic array integration: Combine antibody-based detection with systematic genetic interaction screens to place YLR255C in functional networks.

These approaches can help develop hypotheses about YLR255C function despite the current lack of documented protein-protein interactions or high-throughput expression data.

What are the optimal conditions for using YLR255C Antibody in Western blot applications?

Optimizing Western blot conditions for YLR255C Antibody requires attention to several key parameters:

Sample Preparation:

  • Extract proteins using mechanical disruption (e.g., glass bead lysis) in the presence of protease inhibitors

  • Include phosphatase inhibitors if investigating potential phosphorylation states

  • Typical protein loading: 20-50 μg total protein per lane

Electrophoresis and Transfer Parameters:

  • 10-12% SDS-PAGE gel recommended

  • Semi-dry transfer: 15V for 30 minutes or wet transfer at 100V for 1 hour

  • PVDF membrane preferable over nitrocellulose for potentially low-abundance dubious ORF products

Antibody Incubation:

  • Primary antibody dilution: 1:500 to 1:1000 in 5% BSA/TBST

  • Incubation: Overnight at 4°C with gentle agitation

  • Secondary antibody (anti-rabbit HRP): 1:5000 in 5% non-fat milk/TBST

  • Incubation: 1 hour at room temperature

Detection and Controls:

  • Enhanced chemiluminescence detection system

  • Include wild-type and YLR255C deletion strain lysates as positive and negative controls

  • Consider running recombinant YLR255C protein as a size reference

The optimal conditions may require adjustment based on specific experimental variables and the expression level of YLR255C in your particular strain and growth conditions.

How can I optimize immunoprecipitation protocols for YLR255C given its potentially low expression levels?

Immunoprecipitation of dubious ORF products like YLR255C often requires specialized approaches to overcome potential low abundance challenges:

Pre-IP Considerations:

  • Scale up culture volumes (1-2 liters) to ensure sufficient starting material

  • Consider growth conditions that might induce expression (stationary phase, stress conditions)

  • Use gentle lysis methods to preserve protein-protein interactions

Optimized IP Protocol:

  • Pre-clear lysates with protein A/G beads (1 hour at 4°C)

  • Incubate 2-5 mg total protein with 5-10 μg YLR255C antibody overnight at 4°C

  • Add protein A beads (50 μl slurry) and incubate for 4 hours at 4°C

  • Perform 5 washes with decreasing salt concentration

  • Elute with gentle acidic buffer or by boiling in SDS sample buffer

Crosslinking Options:

  • Consider DSP (dithiobis[succinimidyl propionate]) crosslinking to stabilize transient interactions

  • Formaldehyde crosslinking (1%) for 10 minutes can capture indirect interactions

Verification:

  • Confirm successful IP by Western blot with a portion of the IP sample

  • For mass spectrometry analysis, elute in a urea-based buffer compatible with downstream processing

These optimizations help overcome the challenges associated with potentially low-abundance proteins and may increase the likelihood of identifying functional associations for YLR255C.

How should I interpret Western blot results with YLR255C Antibody given the lack of functional annotation?

Interpreting Western blot results for a poorly characterized protein like YLR255C requires careful consideration:

  • Size verification: Compare the observed molecular weight with the predicted size (check UniProt ID: O13574.1). Discrepancies may suggest post-translational modifications or alternative start sites.

  • Specificity assessment: Always include appropriate controls:

    • Lysate from YLR255C deletion strain should show no band

    • Recombinant YLR255C protein should show a band of predicted size

    • Pre-immune serum should show no specific binding

  • Multiple band interpretation:

    • Multiple bands may represent degradation products, splice variants, or post-translational modifications

    • Verify with additional methods such as mass spectrometry

  • Expression pattern analysis:

    • Compare expression across different growth phases

    • Assess changes under stress conditions

    • Evaluate expression in different genetic backgrounds

  • Context-based interpretation:

    • Compare results with RNA-seq or microarray data if available

    • Consider genomic context and neighboring genes that might provide functional hints

When publishing results, acknowledge the dubious ORF status of YLR255C while presenting evidence for the protein's existence based on your antibody detection.

What approaches can help distinguish true YLR255C signals from potential cross-reactivity with other yeast proteins?

Distinguishing authentic YLR255C signals from cross-reactivity is crucial when working with antibodies against dubious ORFs:

Experimental Approaches:

  • Peptide competition assay: Pre-incubate the antibody with excess synthetic peptide corresponding to the immunogen. True YLR255C signals should disappear.

  • Genetic validation: Compare signals between wild-type and YLR255C deletion strains. Specific signals should be absent in deletion strains.

  • Orthogonal detection methods: Confirm Western blot results using mass spectrometry or a second antibody raised against a different epitope of YLR255C.

  • Immunodepletion experiment: Serially deplete the antibody with recombinant YLR255C, then test if remaining antibody still produces signals.

  • Epitope tagging: Generate a strain expressing epitope-tagged YLR255C and compare detection patterns between the YLR255C antibody and an antibody against the epitope tag.

Analytical Approaches:

  • Bioinformatic epitope analysis: Identify potential cross-reactive proteins through sequence similarity searches focusing on the antibody's epitope region.

  • Quantitative signal analysis: Compare signal intensity patterns across different experimental conditions. Non-specific binding often shows more consistent patterns than specific binding, which typically varies with biological conditions.

These approaches help establish confidence in YLR255C detection, particularly important given that cross-reactivity with other yeast proteins has not been comprehensively ruled out for this antibody.

How can I integrate YLR255C Antibody studies with other antibody-based research approaches in yeast biology?

Integrating YLR255C Antibody research with broader antibody-based approaches enables more comprehensive understanding:

  • Multiplex immunoprecipitation: Combine YLR255C antibody with antibodies against known yeast proteins in sequential or parallel IP experiments to map potential interaction networks.

  • Co-localization studies: Perform dual immunofluorescence with YLR255C antibody and antibodies against organelle markers to determine subcellular localization context.

  • Protein complex analysis: Use YLR255C antibody alongside antibodies against members of known protein complexes (like those in search result ) to test for functional associations.

  • Cross-species comparative studies: Apply YLR255C antibody to lysates from related fungal species alongside antibodies against conserved proteins to explore evolutionary context.

  • Integrated omics approach: Combine antibody-based detection with:

    • Transcriptomics data to correlate protein and mRNA levels

    • Proteomics to identify post-translational modifications

    • Metabolomics to connect YLR255C to metabolic pathways

This integration places YLR255C research within the broader context of yeast biology, potentially revealing functional associations despite its current classification as a dubious ORF .

What can be learned from comparing YLR255C research with studies on similar dubious ORFs in yeast?

Comparative analysis of YLR255C with other dubious ORFs provides valuable research insights:

  • Evolutionary pattern comparison: Many dubious ORFs show unexpected conservation patterns across fungi, suggesting potential functional significance despite their classification. Comparing YLR255C's conservation pattern with other dubious ORFs may reveal shared evolutionary constraints.

  • Expression correlation network: By examining the co-expression patterns of YLR255C and other dubious ORFs across various conditions, researchers can identify potential functional clusters.

  • Phenotypic profile integration: Comparing phenotypic effects of YLR255C deletion with those of other dubious ORF deletions may reveal shared biological roles.

  • Methodological advancement: Successful approaches for studying YLR255C can inform research on other dubious ORFs, establishing best practices for investigating these challenging targets.

  • Reclassification precedents: Some initially classified dubious ORFs have later been confirmed as functional genes. Examining such cases provides a roadmap for potential reclassification of YLR255C if sufficient evidence accumulates.

This comparative approach places YLR255C research within the broader context of non-canonical yeast genes, potentially contributing to revised understanding of the yeast genome annotation .

What are common challenges when using YLR255C Antibody and how can they be addressed?

Researchers working with YLR255C Antibody may encounter several challenges that require specific troubleshooting approaches:

ChallengePossible CausesSolutions
No signal in Western blotLow protein expression, insufficient antibody concentration, ineffective extractionIncrease protein loading (50-100 μg), optimize antibody dilution (try 1:250), use stronger lysis buffer with detergents
Multiple non-specific bandsCross-reactivity, protein degradation, inadequate blockingIncrease blocking time/concentration, optimize antibody dilution, add protease inhibitors during sample preparation
Inconsistent results between experimentsLot-to-lot antibody variation, variable expression conditionsUse consistent antibody lots, standardize growth conditions, include positive control in each experiment
Poor immunoprecipitation efficiencyLow affinity, insufficient antibody amount, inadequate incubationIncrease antibody amount to 10 μg, extend incubation to overnight at 4°C, optimize lysis buffer composition
High background in immunofluorescenceInsufficient blocking, too high antibody concentrationExtend blocking time to 2 hours, dilute antibody further (1:1000), include additional wash steps

For YLR255C specifically, researchers should be aware that its dubious ORF status may contribute to variable detection results. Maintaining consistent experimental conditions and including appropriate controls are particularly important when working with poorly characterized targets.

How can I validate a new lot of YLR255C Antibody before incorporating it into ongoing research?

Proper validation of new antibody lots is essential for research continuity, especially for antibodies targeting dubious ORFs like YLR255C:

Comprehensive Validation Protocol:

  • Side-by-side comparison:

    • Run Western blots with both previous and new lots

    • Use identical samples and conditions

    • Compare band patterns, intensity, and background

  • Specificity testing:

    • Test against wild-type and YLR255C deletion strains

    • Perform peptide competition assay

    • Check cross-reactivity with lysates from related yeast species

  • Functionality assessment:

    • Validate in all intended applications (Western, IP, ELISA)

    • Determine optimal working dilutions for each application

    • Assess lot-specific sensitivity thresholds

  • Documentation:

    • Record lot number, validation date, and results

    • Maintain images of validation experiments

    • Note any differences from previous lots

  • Stability testing:

    • Test antibody performance after different storage durations

    • Determine if aliquoting affects performance

    • Assess freeze-thaw stability

If significant differences are observed between lots, researchers should consider adjusting protocols accordingly or contacting the manufacturer for technical support. For critical ongoing experiments, purchasing larger quantities of a single validated lot may help ensure consistency throughout the research project .

What emerging technologies might enhance YLR255C research beyond traditional antibody applications?

Several cutting-edge technologies show promise for advancing YLR255C research beyond conventional antibody applications:

  • CRISPR-mediated tagging: Endogenous tagging of YLR255C using CRISPR/Cas9 allows for live-cell imaging and affinity purification without relying solely on antibody specificity.

  • Proximity labeling approaches: BioID or APEX2 fusion to YLR255C can identify proximal proteins in living cells, potentially revealing functional associations not detectable by immunoprecipitation.

  • Single-molecule tracking: Combining antibody-based detection with advanced microscopy techniques allows for tracking YLR255C dynamics at the single-molecule level.

  • Spatial transcriptomics integration: Correlating YLR255C protein localization with genome-wide spatial transcriptomic data may reveal co-localized functional networks.

  • AlphaFold-based structural analysis: Computational prediction of YLR255C structure could guide epitope mapping and inform functional hypotheses.

  • Nanobody development: Similar to the llama nanobodies developed for HIV research , engineered smaller antibody fragments against YLR255C might offer improved access to sterically hindered epitopes.

These emerging approaches complement traditional antibody applications while addressing some of their limitations, potentially accelerating functional characterization of dubious ORFs like YLR255C .

How might research on YLR255C contribute to broader understanding of dubious ORFs in eukaryotic genomes?

Research on YLR255C has implications beyond this specific protein, contributing to our understanding of dubious ORFs across eukaryotic genomes:

  • Annotation refinement methodology: Successful characterization of YLR255C could establish a methodological framework for reassessing other dubious ORFs, improving genome annotation accuracy.

  • Evolutionary significance assessment: Understanding why YLR255C is conserved despite its dubious status may provide insights into evolutionary constraints acting on seemingly non-functional genomic elements.

  • Functional genomics advancement: YLR255C research may reveal novel functional categories or regulatory mechanisms that explain the retention of dubious ORFs.

  • Proteome complexity insights: Confirmation of YLR255C expression would contribute to our understanding of the "dark proteome" - proteins predicted but not yet confidently detected.

  • Interspecies comparative analysis: Studying YLR255C homologs in other fungi like Ashbya gossypii may reveal species-specific adaptations and functional divergence patterns.

  • Non-canonical gene product recognition: YLR255C research may help develop improved computational and experimental methods for detecting and validating non-canonical gene products across diverse organisms.

This research has potential implications beyond yeast biology, potentially informing how we approach genome annotation and functional characterization in more complex eukaryotes, including humans, where numerous predicted genes still lack functional validation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.